Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosisMamoru Fujiwara, Makoto Matsumoto, Masanori Kawasaki et al.|Tuberculosis|2017Cited by 163
OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 InhibitorNorimitsu Hariguchi, Makoto Matsumoto, Ryuki Kitamoto et al.|Antimicrobial Agents and Chemotherapy|2020Cited by 130
MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical ConcentrationKelly Wallace Stinson, Lawrence Geiter, Natalia Kurepina et al.|Antimicrobial Agents and Chemotherapy|2016Cited by 57
Delamanid Kills Dormant Mycobacteria <i>In Vitro</i> and in a Guinea Pig Model of TuberculosisXiuhao Chen, Makoto Matsumoto, Hiroyuki Hashizume et al.|Antimicrobial Agents and Chemotherapy|2017Cited by 50
Adduct Formation of Delamanid with NAD in MycobacteriaMikayo Hayashi, Makoto Matsumoto, Akihito Nishiyama et al.|Antimicrobial Agents and Chemotherapy|2020Cited by 21